EP2596364
BLOOD PLASMA BIOMARKERS FOR BEVACIZUMAB COMBINATION THERAPIES FOR TREATMENT OF PANCREATIC CANCER
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
18.7.2011EP published:
16.12.2015EP application number:
11748601.9
EPO information:
European Patent Register
Max expiry date:
17.7.2031
Title:
BLOOD PLASMA BIOMARKERS FOR BEVACIZUMAB COMBINATION THERAPIES FOR TREATMENT OF PANCREATIC CANCER
Timeline
Today
18.7.2011EP application
16.12.2015EP Publication
Owner
Name:
F.Hoffmann-La Roche AGAddress:
Grenzacherstrasse 124, 4070, Basel, CH
Inventor
Name:
DELMAR, PaulAddress:
Basel, CH
Name:
FOERNZLER, DorotheeAddress:
Lenzburg, CH
Name:
KRAUSE, FriedemannAddress:
Penzberg, DE
Name:
SCHERER, StefanAddress:
California, US
Priority
Number:
10170004Date:
19.7.2010Country:
EP
Classification
Categories:
G01N 33/574